drugset / Trial / NCT07041385

Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women

NCT07041385

Not yet recruiting 340 enrolled Shalamar Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition. Existing literature suggests that the 150 mg aspirin dose may exhibit superior efficacy, yet inconclusive evidence exists in our local setting.

Timeline

Start
2025-11-01
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 75 mg
Subject Aspirin Small molecule 150 mg

Indications